Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2018
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Diagnostic use
- 07 Aug 2018 Status changed from not yet recruiting to recruiting.
- 03 Mar 2018 Planned End Date changed from 1 Jul 2020 to 1 Jul 2021.
- 03 Mar 2018 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2020.